Inhibrx
INBX
#5472
Rank
NZ$2.23 B
Marketcap
NZ$153.75
Share price
-4.94%
Change (1 day)
501.30%
Change (1 year)

Market capitalization of Inhibrx (INBX)

Market cap: NZ$2.23 Billion

As of December 2025 Inhibrx has a market cap of NZ$2.23 Billion. This makes Inhibrx the world's 5472th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Inhibrx from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$2.23 B480.4%
2024NZ$0.38 B-86.44%
2023NZ$2.84 B68.12%
2022NZ$1.69 B-30.35%
2021NZ$2.42 B40.82%
2020NZ$1.72 B

End of Day market cap according to different sources

On Dec 8th, 2025 the market cap of Inhibrx was reported to be:

NZ$2.35 Billion
by Nasdaq info icon info icon
NZ$2.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$1.70 B-23.61%๐Ÿ‡บ๐Ÿ‡ธ USA